Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$13.98 USD
-0.10 (-0.71%)
Updated May 3, 2024 04:00 PM ET
After-Market: $13.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 381 - 400 ( 455 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Reported in-line second quarter results with total sales of $5.0 billion (up 2%) and adjusted
Provider: G.RESEARCH, LLC
Analyst: KEDRA K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
We are dropping coverage due to the departure of the covering research analyst
Provider: NATIONAL ALLIANCE CAPITAL MARKETS
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
INITIATING COVERAGE AT BUY AND TARGET PRICE $64
Provider: NATIONAL ALLIANCE CAPITAL MARKETS